accountA deal with Nycomed would bolster Takeda���s presence in treatments for gastric, respiratory and inflammatory disorders. The Swiss pharmaceutical company has a presence in 70 countries, with Europe accounting for 50 percent of sales and emerging markets...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Takeda in Talks to Buy Nycomed for as Much as $14 Billion
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account